Skip to content

Hydrogen Inhalation for Health and Exercise Performance

Hydrogen Inhalation for Health and Exercise Performance

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03846141
Acronym
HIHEP
Enrollment
20
Registered
2019-02-19
Start date
2018-01-15
Completion date
2018-09-15
Last updated
2019-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise Performance

Brief summary

In this randomized double-blind, placebo-controlled, crossover pilot trial, we evaluated the effects of 7-day H2 inhalation on exercise performance outcomes and serum hormonal and inflammation profiles in a cohort of young men and women.

Detailed description

All participants were allocated to receive either gaseous hydrogen (4%) or placebo (room air) by 20-min once-per-day inhalation for 7 days, with wash-out period of 7 days to prevent the residual effects of interventions across study periods. The primary treatment outcome was the change in running time-to-exhaustion from baseline to day 7. Additionally, assessment of other exercise performance endpoints and clinical chemistry biomarkers were performed at baseline and after 7 days after each intervention.

Interventions

OTHERPlacebo

Inhalation of room air for 20 min per day during 7 days

Inhalation of 4% hydrogen for 20 min per day during 7 days

Sponsors

University of Novi Sad, Faculty of Sport and Physical Education
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

Age ≥ 18 -35 years Body mass index 20 - 25 kg/m2 Free of major diseases Physically active Must be able to give written informed consent

Exclusion criteria

Use of any dietary supplements within 4 weeks before study commences Abnormal values for lab clinical chemistry (\> 2 SD)

Design outcomes

Primary

MeasureTime frameDescription
Change in exercise performanceChange from baseline running time-to-exhaustion at 7 daysRunning time-to-exhaustion

Secondary

MeasureTime frameDescription
Change in exercise performanceChange from baseline maximal voluntary isometric strength at 7 daysMaximal voluntary isometric strength
Change in clinical chemistry biomarkerChange from baseline serum insulin at 7 daysInsulin

Countries

Serbia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026